Subtle Medical has raised $12.2 million in a series A round. The Menlo Park, CA-based company develops artificial intelligence-powered software solutions for medical imaging enhancement.
The round was led by 3E Bioventures Capital with participation from Fusion Fund, Data Collective, Delta Capital, Tsingyuan Ventures and continued support from other seed investors. Several key European investors also participated in the round, including Crista Galli Ventures (UK) and Nina Capital (Spain).
The new round of financing will be used to further boost Subtle’s product pipeline and to pursue rapid geographic expansion to meet consumer demand, which has seen an uptick since Covid-19 began as centers require more flexibility to perform additional cleaning protocols between patients and the ability to increase capacity to accommodate the surge in postponed scan volume.
“Subtle Medical is paving the way for a new generation of AI-powered medical imaging. In a short time, the company has proven to have a profound impact on the radiology community, and the value they bring to improve patient care and increase scanner capacity is instrumental and timely in the current healthcare environment,” Dr. Lue Sun, Vice President at 3E Bioventures, said in a release. “With their ambitious and promising team leading the way, we believe our partnership will help accelerate their growth.”